COMPASS Pathways

COMPASS PathwaysCMPS

Price

$ 6.94

Market Capitalization

$ 474.56 M

Shares Outstading

68.381 M

Change

$ 0.1

Percentage Change

1.46 %

Country

United Kingdom 🇬🇧

Industry

Medical Care Facilities

Healthcare

Exchange

NASDAQ Global Select

IPO

2020-09-18

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the

EPS of COMPASS Pathways ( CMPS)

EPS : -2.35

COMPASS Pathways has EPS of -2.35 .The current price of COMPASS Pathways is $6.94 (1.46 %).

Earnings Per Share (EPS) is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It is calculated by dividing the company's net income by the number of outstanding shares. EPS is a key indicator of a company's profitability and is often used by investors to assess a company's financial performance on a per-share basis. Higher EPS generally indicates higher profitability and can influence stock valuation.
EPS of COMPASS Pathways from 2020 to 2024
Year on Year EPS of COMPASS Pathways
EPS
YearEPSChange %
2023-2.3508.8%
2022-2.16021.35%
2021-1.780-33.9%
2020-2.693
Market Cap of Magnificent 7

Stock Ticker

Market Cap

Price

Change

Price(30 Days)

Country

$ 3.285 T

$ 214.24

0.55%

$ 1.17

United States🇺🇸

$ 3.282 T

$ 441.58

0.12%

$ 0.52

United States🇺🇸

$ 3.188 T

$ 129.61

3.52%

$ 4.41

United States🇺🇸

$ 2.173 T

$ 176.74

-1.57%

$ -2.82

United States🇺🇸

$ 1.913 T

$ 183.83

-1.64%

$ -3.06

United States🇺🇸

$ 1.788 T

$ 7.39041

-2.13%

$ -0.16

Saudi Arabia🇸🇦

$ 1.279 T

$ 504.1

-0.93%

$ -4.74

United States🇺🇸

NEWSLETTER

MarketStreak weekly Newsletter

Get weekly Stock Market/Crypto News and Jobs updates directly to your inbox.

MarketStreak Research

Research

Latest data-backed business trends, research insights, and industry analyses.

MarketStreak Inc.

TEXAS, USA 🇺🇸

Disclaimer : The content on our website, including hyperlinked sites, associated applications, forums, blogs, and social media accounts, is for general information only and sourced from third-party providers. We offer no warranties regarding the content's accuracy or updatedness. Please note that our content should not be considered financial or legal advice. Always conduct thorough research and consult with a financial advisor before making any decisions. Trading is a high-risk activity that can lead to significant losses, so please seek professional guidance before making any trading decisions. Our content is not meant to be a solicitation or offer.